National Health Investors (NYSE:NHI) Director Acquires $63,768.50 in Stock

National Health Investors, Inc. (NYSE:NHI) Director Robert Mccabe, Jr. bought 890 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $70.55 on Thursday. The firm has a 50 day moving average of $76.55 and a 200 day moving average of $79.91. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $3.42 billion, a price-to-earnings ratio of 22.76, a price-to-earnings-growth ratio of 3.85 and a beta of 0.52. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.39). National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The firm had revenue of $115.13 million for the quarter, compared to analysts’ expectations of $70.22 million. During the same period in the prior year, the firm earned $1.15 EPS. National Health Investors’s revenue for the quarter was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts anticipate that National Health Investors, Inc. will post 4.93 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be given a dividend of $0.92 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.2%. National Health Investors’s dividend payout ratio is currently 118.71%.

Institutional Investors Weigh In On National Health Investors

Hedge funds and other institutional investors have recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors in the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC raised its stake in shares of National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares during the period. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors in the fourth quarter valued at $33,000. GAMMA Investing LLC raised its stake in shares of National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares during the period. Finally, Key Capital Management INC purchased a new stake in shares of National Health Investors in the fourth quarter valued at $47,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

NHI has been the subject of a number of research reports. BMO Capital Markets dropped their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday. Wells Fargo & Company dropped their target price on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 target price on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Truist Financial dropped their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $84.57.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.